Notas do episódio
The most dangerous window in severe depression occurs during the four to eight week lag before conventional antidepressants take effect, a vulnerable period where suicide risk peaks. A breakthrough randomized controlled trial demonstrates that frontline add-on intravenous ketamine completely eliminates this agonizing delay, delivering meaningful clinical relief within 48 hours.
Discover how just four infusions achieved a 58% response rate, cleared suicidal ideation to absolute zero within five days, and sustained recovery at four weeks. We also unpack the vital anxiety paradox that dictates…
Site: rss.com

